Brief Article
Copyright ©2010 Baishideng.
World J Gastrointest Oncol. Jan 15, 2010; 2(1): 51-55
Published online Jan 15, 2010. doi: 10.4251/wjgo.v2.i1.51
Table 1 Isocaloric and isonitrogenous constituents of the two groups
Interventional groupControl group
1Taita No.5® (400 mL/bot)3 bot/d4 bot/d
2Amiparen® (400 mL/bot)1 bot/d1 bot/d
3Intralipid® (100 mL/bot)2 bot/d
50% glucose (20 mL/amp)6 amp/d
Total volume (mL)18002120
Total calories (kcal)10401040
1Taita No.5® (10% glucose), Taiwan Otsuka Pharmaceutical Co., Ltd;
2Amiparen® (10% crystalline amino acid), Japan Otsuka Pharmaceutical Co., Ltd;
3Intralipid® (20% fatty acid), Fresenius Kabi Pharmaceutical Co., Ltd.
Table 2 Demographic data and postoperative complications in the two groups
ParameterInterventional group n = 10Control group n = 10P
GenderNS
Male/Female5/53/7
Age (years ± SE)58.9 ± 2.967.2 ± 3.6NS
Primary lesionNS
Colon cancer76
Gastric cancer34
ComplicationNS
Thrombophlebitis34
Fever11
Wound infection11
Pneumonia10
Table 3 Routine blood and biochemical data before and after operation between the two groups
VariablesPre-operativePost-operativeP
White blood cells (/μL)NS
Intervention group5667.0 ± 767.56564.0 ± 665.3
Control group6222.0 ± 579.46675.0 ± 704.4
Hemoglobin (g/dL)NS
Intervention group11.9 ± 0.311.4 ± 0.3
Control group11.8 ± 0.611.7 ± 0.5
Hematocrit (%)NS
Intervention group35.8 ± 0.734.1 ± 1.1
Control group35.7 ± 1.534.6 ± 1.5
Total lymphocyte count (/μL)NS
Intervention group1596.3 ± 215.11177.8 ± 150.9
Control group1485.9 ± 166.01174.9 ± 98.8
Triglyceride (mg/dL)< 0.05
Intervention group102.2 ± 8.389.0 ± 13.1
Control group105.1 ± 18.9109.6 ± 9.7
Cholesterol (mg/dL)NS
Intervention group155.0 ± 6.7143.6 ± 8.5
Control group170.3 ± 11.7150.8 ± 11.0
Blood urea nitrogen (mg/dL)NS
Intervention group9.7 ± 1.113.2 ± 0.9
Control group11.9 ± 2.313.9 ± 1.4
Creatinine (mg/dL)NS
Intervention group0.9 ± 0.10.7 ± 0.1
Control group1.0 ± 0.10.8 ± 0.1
Aspartate aminotransferase (IU/L)NS
Intervention group13.2 ± 2.414.0 ± 1.6
Control group12.2 ± 1.813.4 ± 1.8
Alanine aminotransferase (IU/L)NS
Intervention group6.1 ± 1.39.5 ± 1.3
Control group6.6 ± 1.010.2 ± 1.4
Total bilirubin (mg/dL)NS
Intervention group0.5 ± 0.080.4 ± 0.05
Control group0.5 ± 0.080.4 ± 0.04
Glucose (gm/dL)NS
Intervention group86.9 ± 3.8122.1 ± 10.8
Control group88.7 ± 4.9119.7 ± 9.8
Insulin (IU/mL)NS
Intervention group8.3 ± 1.218.1 ± 2.7
Control group9.8 ± 2.720.1 ± 3.8
C-peptide (ng/dL)NS
Intervention group1.8 ± 0.54.3 ± 0.6
Control group1.8 ± 0.54.9 ± 1.0
Na (mmol/L)NS
Intervention group139.6 ± 0.7136.3 ± 1.2
Control group139.3 ± 1.1137.2 ± 1.1
K (mmol/L)NS
Intervention group4.2 ± 0.23.8 ± 0.2
Control group4.0 ± 0.13.8 ± 0.1
Cl (mmol/L)NS
Intervention group105.3 ± 0.6102.4 ± 1.3
Control group106.0 ± 0.9101.9 ± 0.8
NS: Not significant.
Table 4 Anthropometry and various nutritional parameters before and after operation between the two groups
VariablesPre-operativePost-operativeP
Body weight (kg)NS
Intervention group56.9 ± 3.655.6 ± 3.9
Control group54.8 ± 3.052.2 ± 2.7
Triceps skin fold (cm)NS
Intervention group12.9 ± 2.013.3 ± 2.0
Control group13.4 ± 2.213.5 ± 2.1
Mid-arm circumference (cm)NS
Intervention group25.1 ± 1.224.3 ± 1.1
Control group24.4 ± 0.824.2 ± 0.9
Prealbumin (mg/dL)< 0.05
Intervention group22.0 ± 1.917.7 ± 1.6
Control group21.4 ± 2.319.9 ± 1.2
Transferrin (mg/dL)NS
Intervention group254.4 ± 21.0186.2 ± 18.2
Control group224.8 ± 10.8173.4 ± 12.5
Albumin (gm/dL)NS
Intervention group4.0 ± 0.13.5 ± 0.1
Control group3.9 ± 0.13.4 ± 0.1
Nitrogen balanceNS
Intervention group-5.5 ± 1.4-6.5 ± 1.3
Control group-5.6 ± 1.3-6.4 ± 1.4